Insights+ Exclusive: Novel Approvals of February 2020
The US FDA has approved multiple NDAs and BLAs in Feb 2020, leading to treatments for patients and advances in health care. The
[Read More...]
PharmaShots
PharmaShots’ Key Highlights of Fourth Quarter 2019
1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019 Date – Oct 01, 2019 Product – Zirabev
[Read More...]
PharmaShots Wishes you a Merry Chritmas and a Happy New Year on the Behalf of Team Octavus!
Shots: May all the sweet magic of Christmas conspire to gladden your heart and fill every desire We would like to Thank You
[Read More...]
PharmaShots’ Key Highlights of Third Quarter 2019
The third quarter of 2019 has ended with major acquisitions in the pharma and biotech industry along with multiple approvals. Starting with the
[Read More...]
PharmaShots Celebrates Successful Accomplishment of One Year
Shots: Team PharmaShots started their journey on 25 July 2018 and is proudly announcing their completion of one year, with many more to
[Read More...]
PharmaShots’ Key Highlights of Second Quarter 2019
The second quarter of 2019 has ended with major acquisitions in pharma and biotech industry. Moving with the latest acquisition of Allergan for
[Read More...]
PharmaShots Awarded as Feedspot’s Top 50 Pharma Blog
Shots: Team PharmaShots proudly announce that we are awarded as Top 50 Pharma Blog by Feedspot We are thankful to Feedspot for identifying
[Read More...]